Dr. Athanasios G. Dousmanis, MD

Dr. Dousmanis practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Dousmanis' NPI, 1346331477, was assigned on September 27, 2006. Dr. Dousmanis graduated from Weill Cornell Medicine in 1997. Dr. Dousmanis holds New York license 213793-1.

Dr. Dousmanis' primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Dousmanis' primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Dousmanis is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Dousmanis to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dousmanis practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Dousmanis' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Dousmanis is licensed in New York.

Dmand AI lists alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Dousmanis treats.

CMS data shows 685 Medicare services from Dr. Dousmanis across 11 procedure codes in 2024, for 276 Medicare patients. Medicare paid $70,902 for them. Every service was in an office.

CMS counts 276 Medicare patients who saw Dr. Dousmanis in 2024. The largest group is 75 to 84, with 112 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dousmanis' median patient age at 56, with 63% women.

In 2024, Dr. Dousmanis wrote 1,064 Medicare Part D claims for 222 patients. 94% of them were for generic drugs. CMS names the drug for 844 of them, across 31 drugs with 11 or more claims each, at $104,288 in total drug cost. In 2023, CMS named 844 claims across 27 drugs.

Dr. Dousmanis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dousmanis as offering telehealth.

Dmand AI links 3 papers to Dr. Dousmanis in 2015. The most frequent topics are Immunosuppressive Agents, Paraneoplastic Syndromes, Nervous System and Tacrolimus. Dr. Dousmanis' most frequent co-authors are Robert B. Darnell, MD, Jerome J. Graber, MD, MPH and Ronen Marmur, MD.

CMS Open Payments shows 7 general payments to Dr. Dousmanis from 3 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 91% of the total. Abbvie Inc. paid the most, $128.

Dmand AI lists 1 award for Dr. Dousmanis, most recently CMS Stage 1 2012 in 2012.

Dr. Dousmanis graduated from Weill Cornell Medicine in 1997.

Dr. Dousmanis is in network with 10 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.